jagomart
digital resources
picture1_April 2022 Als


 195x       Filetype PDF       File size 0.68 MB       Source: med.virginia.edu


File: April 2022 Als
nutrition issues in gastroenterology series 220 carol rees parrish ms rdn series editor nutritional care of the patient with amyotrophic lateral sclerosis stephanie dobak amyotrophic lateral sclerosis als is a ...

icon picture PDF Filetype PDF | Posted on 13 Jan 2023 | 2 years ago
Partial capture of text on file.
       NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #220
        Carol Rees Parrish, MS, RDN, Series Editor
          Nutritional Care of the Patient 
          with Amyotrophic Lateral Sclerosis
                                  Stephanie Dobak
        Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease with no effective treatment 
        to cure, halt or reverse disease advancement. ALS can impact a person’s ability to speak, eat, move, and 
        breathe. Malnutrition is a common complication of ALS and is associated with reduced survival time. 
        The objective of this review is to discuss the nutritional implications of ALS and supportive strategies.
        OVERVIEW
             myotrophic lateral sclerosis (ALS) is a        discuss the nutritional implications of ALS and 
             progressive motor neuron disease with no       supportive strategies.
        Aeffective treatment to cure, halt, or reverse 
        disease advancement. Also known as Lou Gehrig’s     Etiology and Disease Trajectory 
        disease, ALS is characterized by the gradual loss   Most ALS cases (90-95%) are considered sporadic, 
        of voluntary muscle movement. Depending on          occurring randomly. Familial ties account for the 
        disease progression, a person with ALS (PALS)       remaining 5-10% cases with roughly 25-40% 
        may lose their ability to speak, eat, move, and,    of these cases caused by known gene mutations 
        eventually, breathe. The average life expectancy    (most commonly, C9ORF72 and SOD1). Military 
        after diagnosis is 2-5 years.                       veterans are twice as likely to develop ALS, 
                                                                                                       5
           Malnutrition in PALS is common, with studies     regardless of service branch or time period.
                                                      1,2
        varying its prevalence from 16% to 55%.                 Rate and trajectory of disease progression vary 
        Malnutrition, lower weight, and weight loss are     among individuals. Onset typically begins in one of 
        associated with reduced survival time.3,4 However,  two regions: limb or bulbar (or both). Limb onset 
        many barriers exist to consuming adequate calories  ALS arises in the arms and legs, impacting manual 
        and protein. The objective of this review is to     dexterity and mobility. Bulbar onset ALS manifests 
                                                            in the face and neck area, altering swallowing 
        Stephanie Dobak, MS, RD, LDN, CNSC, Clinical        function and speech. PALS with limb onset can 
        Dietitian III Department of Neurology Jefferson     later develop bulbar issues and vice versa. Less 
        Weinberg, ALS Center, Philadelphia, PA                                           (continued on page 62)
        60                                                           PRACTICAL GASTROENTEROLOGY • APRIL 2022
         Nutritional Care of the Patient with Amyotrophic Lateral Sclerosis
          NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #220
         (continued from page 60)
         commonly, onset can present as respiratory distress 
         from weakness in the diaphragm/intercostal region. 
         Disease progression can be quantified using a 
         validated tool, the ALS Functional Rating Scale-
         Revised (ALSFRS-R). The ALSFRS-R measures 
         12 aspects of physical function categorized within 
         4 functional domains: bulbar, fine motor, gross 
         motor, and respiratory. Each aspect of self-reported 
         function is scored from 0 to 4, with the total score 
         from all 12 domains ranging from 0 (no function) 
         to 48 (highest function).
         Treatment
         There are currently two drugs approved for the 
                                                 ®           ®
         treatment of ALS: riluzole (Rilutek , Tiglutik , 
                   ®                              ®
         Exservan ) and edaravone (Radicava ). Riluzole 
         is a glutamate antagonist approved by the FDA 
         in 1995 to extend life by 2-4 months for PALS. 
         Edaravone, a free-radical scavenger, was approved           Figure 1. G-tube-EN Product Connector – Bolink D 
         by the FDA in 2017 to help prevent neuronal                 Cap on to a Tetra DreamCap™ Container
         damage from oxidative stress. The efficacy of 
         edaravone in PALS is controversial. While earlier           (BMI) at diagnosis to be significantly and inversely 
                                                                                                        8
         trials showed edaravone slowed the progression of           associated with ALS survival.  Paganoni et al. 
         functional loss (as determined by ALSFRS-R) in              noted an obesity paradox in PALS: a “U”-shaped 
                                         6
         patients with early-stage ALS,  a later trial noted no      association between BMI and mortality, with 
         significant differences in either disease progression       highest survival seen in the BMI range of 30–35 
                                    7                                     2 9
         or respiratory function.  Unfortunately, neither            kg/m .  Though not yet fully understood, decreased 
                                                                                                                 2
         riluzole nor edaravone reverse motor neuron death           survival with BMI greater than 35 kg/m  may be 
         or treat the underlying cause of ALS.                       due to weight-induced physical activity burden and 
             Lack of treatment options lead many                     respiratory distress.
         PALS to seek alternative therapies. Dietary                     Malnutrition in PALS is difficult to diagnose 
         supplement use is common though may result                  using typical malnutrition criteria. Muscle loss from 
         in drug-nutrient or nutrient-nutrient interactions.         nerve degeneration is characteristic of the disease. 
         Providers and registered dietitians (RDs) should            Weight loss may be a result of disease-related 
         review supplement use routinely to ensure safe              muscle loss. Edema due to immobility is common 
         consumption. ALSUntangled (alsuntangled.com),               in the extremities. Handgrip strength measurement 
         a website created to educate on alternative and             may not be plausible depending on manual dexterity 
         off-label treatments advertised for PALS, reviews           and may signify disease progression instead of 
         many dietary supplements. Currently, clinical trials        malnutrition. Oral intake may remain unchanged, 
         on the dietary supplements tauroursodeoxycholic             but disease-related hypermetabolism may result 
         acid and theracurmin are ongoing. Last, certain             in weight loss. The Subjective Global Assessment 
         nutrient deficiencies (e.g., vitamin B12, copper,           (SGA) and Global Leadership Initiative for 
         thiamine) may mimic ALS signs and symptoms                  Malnutrition (GLIM) should be considered when 
         and should be ruled out during diagnostic work-up.          diagnosing malnutrition in PALS. Although these 
                                                                     nutritional assessment tools incorporate some of 
         Malnutrition                                                the above criteria, malnutrition (as determined by 
         Malnutrition is a prognostic indicator for survival         SGA and GLIM) is noted to be an independent risk 
                                                                                                        10
         in PALS. Dardoitis et al. noted body mass index             factor for reduced survival time.
         62                                                                   PRACTICAL GASTROENTEROLOGY • APRIL 2022
                                         Nutritional Care of the Patient with Amyotrophic Lateral Sclerosis
                                                  NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #220
        Nutrition Needs                                         Table 1. Common Barriers to Consuming Adequate  
        Early in the disease, PALS may lose weight despite              Nutrition for Persons with ALS 
        no changes in dietary habits. Bouteloup et al. 
                                                   11
        noted 50% of PALS are hypermetabolic.  Mean               Chewing difficulty and dysphagia
        measured resting energy expenditure was 19.7 +/-          Hypermetabolism
        6.4% higher than calculated by the Harris Benedict 
        equation (HBE). Despite muscle loss with disease          Self-feeding difficulty
        progression, the authors noted that 80% of PALS           Communication challenges
        showed no change in metabolic status over time. 
        Typically, energy requirements are estimated at           Decreased ability to grocery shop and cook
        30-35 kcal/kg/day. Alternatively, the Kasarskis           Fatigue
        equation has been proposed to estimate energy 
                               12
        requirements in PALS.   The equation incorporates         Shortness of breath
        the HBE and 6 questions from the ALSFRS-R. A              Constipation
        web-based calculator can be found here: mednet.
        mc.uky.edu/alscalculator                                  Sialorrhea
            Protein needs in PALS are not well studied.           Depression and decreased appetite
        While adequate calorie and protein intake is 
        necessary to prevent malnutrition-related muscle          Frontotemporal dementia
        loss, it is not known if increased protein intake 
        mitigates disease-related muscle loss. In the 
        absence of available data, registered dietitians        subconscious hesitation to move bowels related to 
        use varying calculations for protein needs, most        ambulatory weakness, medication side effects, and 
                                       13                                                       16
        commonly 0.6-1.5 gm/kg/day.                             inadequate fiber and fluid intake.  Constipation can 
                                                                make eating uncomfortable, negatively impacting 
        Barriers to Adequate Nutrition Intake                   intake. Constipation is treated with lifestyle 
        Despite the emphasis on adequate energy intake,         modifications (fiber [caution with use in decreased 
        PALS on average only consume 84% of calorie             mobility as fiber can worsen constipation], fluid; 
                      14
        requirements.  Many barriers exist to consuming         exercise when appropriate) and bowel medications 
                                                                                                            16
        adequate calories. (Table 1)                            (stool softeners, laxatives, suppositories).  Gut 
                                                                microbiota may be altered in PALS,17 and research 
                                                                                                          18
        Hypermetabolism                                         on probiotic supplementation is ongoing.
        As mentioned previously, PALS can be 
        hypermetabolic. High calorie foods and oral             Sialorrhea
        supplements are often prescribed to combat              Sialorrhea (excessive saliva) is not caused by saliva 
        increased calorie requirements.                         overproduction in PALS, but rather weakened 
                                                                oropharyngeal muscles and subsequent difficulty 
        Dysphagia                                               managing saliva. Untreated sialorrhea can result in 
        Dysphagia from oral muscle spasticity and               drooling, choking on saliva, and difficulty speaking. 
                                                          15
        flaccid weakness impacts up to 85% of PALS.             Sialorrhea is often treated with glycopyrrolate, 
        It is the result of degeneration of cortical motor      off-label medications (amitriptyline, scopolamine, 
        neurons, corticobulbar tracts, and brainstem nuclei.    atropine), or botulinum toxin injections into the 
        Mechanically altered diets can help reduce chewing      parotid or submandibular gland. Attention to 
        difficulty and aspiration risk.                         hydration is particularly important in PALS with 
                                                                sialorrhea.  
        Constipation
        Constipation is one of the most frequent side effects   Mood disorders, fatigue 
        of ALS, presumed to be caused by decreased              and frontotemporal dementia (FTD)
        activity, diminished diaphragmatic function,            Mood disorders (e.g., depression) can result in 
        PRACTICAL GASTROENTEROLOGY • APRIL 2022                                                                 63
         Nutritional Care of the Patient with Amyotrophic Lateral Sclerosis
          NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #220#220
         Table 2. Nutrition-related Roles of Multidisciplinary Team Members
          Team member                 Nutrition barrier                Nutrition-related role
          Registered dietitian        •  Hypermetabolism               •  Conducts nutrition assessments to identify 
                                      •  Dysphagia                       malnutrition and nutrition risk (i.e., nutrition-
                                                                         focused physical examination, diet and weight 
                                                                         history, self-feeding ability, food preparation 
                                                                         ability, access to food, chewing/swallowing 
                                                                         function, appetite, dietary supplement use, and 
                                                                         length of time to complete meals)
                                                                       •  Calculates nutrition and hydration needs and 
                                                                         provides recommendations to meet needs
                                                                       •  Suggests dietary alterations to meet 
                                                                         recommended texture modifications
                                                                       •  Inquires about constipation and offers dietary 
                                                                         adjustments
                                                                       •  When appropriate, introduces the topics of 
                                                                         gastrostomy tubes and EN, determines EN 
                                                                         regimen, and educates on feeding tube care 
                                                                         and EN administration
          Neurologist, palliative     •  Symptom management            •  Order appropriate medications for symptom 
          care physician, and           (sialorrhea, constipation)       management
          other providers             •  Decision-making               •  Aid in gastrostomy placement decision-making
          Speech Language             •  Dysphagia                     •  Assesses dysphagia and aspiration risk
          Pathologist                 •  Communication challenges      •  Suggests diet texture modifications and 
                                                                         compensatory swallowing techniques
                                                                       •  Provides guidance on communication 
                                                                         strategies and devices
          Assistive technology        •  Communication challenges      •  Provides guidance on communication devices
          specialist
          Pulmonologist and           •  Fatigue                       •  Address respiratory-related fatigue
          respiratory therapist
          Occupational therapist      •  Difficulty self-feeding,      •  Teach adaptive techniques for mealtimes and 
          and physical therapist        preparing meals and grocery      energy conservation
                                        shopping
          Social worker               •  Food insecurity               •  Helps procure meals
          Mental health worker        •  Mental health challenges      •  Assesses mental health and suggests treatment 
                                        impacting appetite/intake        options
         Key: EN, enteral nutrition
         poor appetite. Counseling, support groups, and                A multidisciplinary team approach is optimal 
         medications may help treat mood disorders.                to identify and address nutrition barriers, with each 
         Fatigue often leads to skipped meals and is               team member having a unique role. (Table 2) In 
         typically addressed with respiratory aid. FTD can         fact, multidisciplinary clinics have been shown to 
                                                                                                                     19
         inhibit adequate energy intake. FTD impacts up to         increase median survival rate by 6-10 months.
         15% of PALS and causes alterations in behavior,                                           (continued on page 66)
         personality and language skills.
         64                                                                  PRACTICAL GASTROENTEROLOGY • APRIL 2022
The words contained in this file might help you see if this file matches what you are looking for:

...Nutrition issues in gastroenterology series carol rees parrish ms rdn editor nutritional care of the patient with amyotrophic lateral sclerosis stephanie dobak als is a progressive motor neuron disease no effective treatment to cure halt or reverse advancement can impact person s ability speak eat move and breathe malnutrition common complication associated reduced survival time objective this review discuss implications supportive strategies overview myotrophic aeffective also known as lou gehrig etiology trajectory characterized by gradual loss most cases are considered sporadic voluntary muscle movement depending on occurring randomly familial ties account for progression pals remaining roughly may lose their these caused gene mutations eventually average life expectancy commonly corf sod military after diagnosis years veterans twice likely develop studies regardless service branch period varying its prevalence from rate vary lower weight among individuals onset typically begins one...

no reviews yet
Please Login to review.